Intermittent fluconazole dosing in patients with onychomycosis: Results of a pilot study

Journal of the American Academy of Dermatology

Volumn 35, Issue 2 PART I, 1996, Pages 216-219

  Assaf, Richard R ^a   Elewski, Boni E ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; CICLOPIROXOLAMINE; ECONAZOLE; FLUCONAZOLE; OXICONAZOLE; SULCONAZOLE; TERBINAFINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DOSE RESPONSE; FEMALE; FINGER NAIL; HUMAN; MALE; ONYCHOMYCOSIS; PRIORITY JOURNAL; SCHOOL CHILD; TOE; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; CHILD; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUCONAZOLE; FOLLOW-UP STUDIES; FOOT DERMATOSES; HAND DERMATOSES; HUMANS; MALE; MIDDLE AGED; ONYCHOMYCOSIS; PILOT PROJECTS; REMISSION INDUCTION;

EID: 0029761649     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0190-9622(96)90327-8     Document Type: Article

References (12)

1. Korting HC, Schafer-Korting M. Is tinea unguium still widely incurable? A review three decades after the introduction of griseofulvin. Arch Dermatol 1992;128:243-8.
2. Roberts DT. Oral therapeutic agents in fungal nail disease. J Am Acad Dermatol 1994;31(suppl):S78-81.
3. Wildfeuer A, Faergemann J, Laufen H, et al. Bioavailability of fluconazole in the skin after oral medication. Mycoses 1994;37:127-30.
4. Hay RJ. Pharmacokinetic evaluation of fluconazole in skin and nails. Int J Dermatol 1992;31(suppl 2):6-7.
5. Grant SM, Clissold SP. Fluconazole: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses. Drugs 1990;39:877-916.
6. Pieponnen T, Blomqvist K, Brandt H, et al. Efficacy and safety of itraconazole in the long-term treatment of onychomycosis. J Antimicrob Chemother 1992;29:195-205.
7. Baudraz-Rosselet F, Rakosi T, Will PB, et al. Treatment of onychomycosis with terbinafine. Br J Dermatol 1992; 126(suppl 39):36-9.
8. Kuokkanen K, Alava S. Fluconazole in the treatment of onychomycosis caused by dermatophytes. J Dermatol Treat 1992;3:115-7.
9. Coldiron B. Recalcitrant onychomycosis of the toenails successfully treated with fiuconazole. Arch Dermatol 1992;128:909-10.
10. Nahass GT, Sisto M. Onychomycosis: successful treatment with once-weekly fiuconazole. Dermatology 1993;186:59-61.
11. Hay RJ, Baran R, Moore MK, et al. Candida onychomycosis: an evaluation of the role of Candida species in nail disease. Br J Dermatol 1988;118:47-58.
12. De Doncker P, Pierard GE. Acquired nail beading in patients receiving itraconazole: An indicator of faster nail growth? Clin Exp Dermatol 1994;19:404-6.